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Objectives: Preparation of Voriconazole (VCZ) solid lipid nanoparticles (SLNs) for 
effective ocular delivery for the treatment of fungal keratitis. MethOds: SLNs were 
prepared by solvent emulsification technique using Compritol (lipid), Pluronic F-68 
(surfactant) and sodium taurocholate (co-surfactant). Characterization of SLNs was 
performed by size measurement, in-vitro release, ex-vivo corneal permeation stud-
ies and in-vitro antifungal activity. Results: Particle sizes were found in the range 
of 150-300 depending upon lipid/Smix ratio with good zeta potential. Entrapment 
efficiency of SLNs was found between 40-60% with sustained in vitro drug release 
(> 70% in 12h). The ex-vivo corneal permeation studies exhibited good ocular per-
meation of VCZ from SLNs. Ex-vivo study also supports good ocular permeation of 
VCZ from SLNs when compared with drug suspension. Further, in-vitro antifungal 
activity exhibited the potential of VCZ SLNs. cOnclusiOns: The sustained release 
property with good corneal permeation of VCZ from SLNs encourages its applica-
tion for in-vivo studies and hence could be proposed as an effective carrier for 
ophthalmic administration.
PSS56
the analySiS oF dental care in ukraine at the regional leVel
Zaliskyy O., Shcherba P., Zalis’ka O.
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Objectives: The structure of the overall incidence diseases the mouth and teeth 
morbidity occupy the third place in Ukraine. Thus 99% of the patients served in 
outpatient clinics institutions. The structure of diseases requiring hospitalization 
(approximately 1% of patients), the top spot is occupied odontogenic inflammatory 
diseases and injuries of the maxillofacial face. MethOds: In Ukraine, the avail-
ability of dentists is 4.0 per 10 000 population and 4.5 per 10 000 children. We have 
analyzed the statistical data of the Lviv Regional Department of Health. We found 
that 98% of the population have dental problems. Prevalence of dental caries, tempo-
rary occlusion in 6-years children reached 87.9%, a 12-year-olds - 72.3%. Prevalence 
of chronic catarrhal gingivitis among adolescents aged 12-15 years ranged 70-98% 
and teeth abnormalities in children 7-18 years more than 80%. In Ukraine every-
one requires a prosthetics after 50 years. Results: Main social burden have the 
dental institutions of the state and municipal property. By 2013 there were about 
1.5 million causes to the dental care. We determined that in Lviv region on the 
basis of licenses to practice medicine in dentistry are 248 dentists, who working 
in cities and towns, and only about 10% - in rural areas. From 196th private den-
tal surgeries 89 are situated in the regional center. Danylo Halytsky Lviv National 
Medical University opened and acting university Dental Center from 2012, where 
dentists had treated about 400 000 people, including more than 172 000 children 
each year. Such preventive examinations make it possible to carry out monitoring 
as indicators of dental public health field, to identify the most important risk fac-
tors for dental diseases. cOnclusiOns: The management and pharmacoeconomic 
studies of dental care, identifying optimal funding for state and municipal health 
care institutions for cost-effectiveness use of state funds.
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Objectives: Patients with RA suffer from a higher risk of periodontal attachment 
loss and increased oral inflammation. There were few studies to access the utiliza-
tion of dental care among RA in the Taiwan. The purpose is identify realize analyze 
and discuss the dental use of diabetic patients, and the association between the risk 
of rheumatoid arthritis (RA) and a history of periodontitis. MethOds: retrospective 
cohort studybased on the nationwide, population-based, NHIB used administra-
tive data, case group consisted of 5,506 (age ≥ 18 years) patients with rheumatoid 
arthritis (RA group) as the study group and 22,024 patients without RA attending 
the Outpatient wing of Department of General Medicine formed the control group 
(NRA group). Matched for Age, gender and RUB, Both groups were matched on 1:4.  
Results: More advanced forms of periodontitis were found in RA patients com-
pared with controls. The results showed that RA patients (66.9% of RA) had 5-years 
utilization rate of dental care than non-RA patients (13.9% of non-RA). However, 
people have RA or not, the characteristics of dental use were similar. Only has the 
gender aspects to differ from, when the male suffered from RA, the utilization of 
dental care were not different with the female. cOnclusiOns: we propose that the 
consulting rheumatologists inform the patients that they have a higher risk of peri-
odontal. this study demonstrates an association between periodontitis and incident 
RA. And the study is limited to lack of BMI, smoking, alcohol status.
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Objectives: Retinal vein occlusion (RVO) causes macular oedema (MO), which 
can lead to vision loss. The present study sought to identify treatment guidelines 
internationally by conducting a systematic review and extensive hand searches. 
The aims were to i) develop a systematic methodology for the identification of 
such guidelines ii) review the guidelines and treatment pathways identified in 
order to propose optimal positioning for an hypothetical intervention for the treat-
ment of MO in RVO, and iii) to identify areas of unmet clinical needs. MethOds: 
Objectives: To assess the cost-effectiveness of nutritional support (high protein 
supplementary diet) versus standard care (regular hospital diet) in preventing pres-
sure ulcers in hospitalised patients at high risk of pressure ulcers and malnutri-
tion. Further, to evaluate the need and value of additional research using value of 
information analysis. MethOds: Analyses were undertaken from the perspective 
of the State health department in Queensland, Australia, using a Markov decision 
model. Evidence for the relative risk (RR) was estimated from a meta-analysis of 
randomised controlled trials; other parameters were systematically identified from 
the literature to populate the model. The incremental net monetary benefit (INB) 
was calculated and a probabilistic sensitivity analysis using Monte Carlo simulation 
was conducted. The expected value of perfect information (EVPI), expected value 
of perfect parameter information (EVPPI), expected value of sample information 
(EVSI), expected total cost of additional research, expected net benefit of sampling 
(ENBS), and the return on investment (ROI) were calculated for an estimated popula-
tion of 125,000 over ten years. Results: At a willingness-to-pay of AU$ 50,000 per 
quality-adjusted life year, the INB was AU$ 530, with a probability of 84% for nutri-
tional support to be the preferred intervention. The population EVPI was AU$ 4.75 
million, the highest EVPPI was for RR at AU$ 2.25 million. For a future randomised 
study investigating the RR of the two interventions, the ENBS would be maximised 
at AU$ 380,000 with 1,200 patients in each arm; from an EVSI of AU$1.6 million and 
total study cost of AU$ 1.2 million. The expected ROI would be 32%. cOnclusiOns: 
Nutritional support is cost-effective in preventing pressure ulcers in high risk hos-
pitalised patients; however, there is uncertainty surrounding the decision and the 
value of this uncertainty is high. A future clinical trial to resolve this uncertainty 
is worthwhile.
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Objectives: The German diagnosis-related groups (G-DRG) have been introduced 
as a reimbursement system for in-patient care. The aim of this study was to report 
on clinic-based data available from the G-DRG browser regarding the impact of 
middle ear implantation as a basis for future health care decision making in 
ear, nose and throat medicine (ENT). MethOds: Using a clinical algorithm, the 
unevaluated D23Z database from 2012 was analyzed to determine epidemiologi-
cal characteristics of patients with different types of hearing losses and receiving 
middle ear implants (MEI). All ICD-10 Codes used for the diagnosis of conduc-
tive (CHL), mixed (MHL) or sensorineural hearing loss (SNHL) were extracted. The 
number of MEI cases reported in the D23Z was analyzed regarding Patient Clinical 
Complexity Level (PCCL), age, sex and duration of stay. The incidence of MEI 
candidates to the total number of ICD-10 codes and per indication were calcu-
lated. Results: According to the D23Z, approximately 30`000 individuals admitted 
to ENT clinics were diagnosed with a hearing loss. About 38% suffered from CHL, 
8% suffered from MHL and 48% suffered from SNHL. The proportion of patients 
who received a MEI per indication were respectively 0.8% for SNHL, 8% for MHL 
and 1% for CHL. Overall, about 466 (1%) patients received a MEI. 49.8% of them 
were men and 50.2% were women. Children aged as young as 1-2 years could 
also receive treatment. All patients had normal-term stay in hospitals with no 
comorbidities or complications (PCCL < 4 in 99.2% of cases) The incidence of MEI 
to the ENT patient base and the German population were respectively 15.5/1,000 
and 0.6/100,000. cOnclusiOns: The overall number of middle ear implantations 
compared to standard treatments is quite low. Analyzing data on MEI available 
from highly-developed DRG systems can be used by other countries for policy 
decision making in ENT.
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The recent U. S. release of Medicare Part B billing data provides unprecedented 
insight into a health care system that reimbursed $77 billion in 2012. Of the 100 
physicians receiving the greatest payments, nearly half were ophthalmologists.  
Objectives: Examine ophthalmologist trends in patient selection and care, 
and implications on system value delivery, based on Medicare and other 
data. MethOds: We examined aggregate and line-item data, comparing the 
100 highest billing ophthalmologists to each other, and to the remaining 16,971, 
identifying patterns in services billed, beneficiaries served, service location, and 
dollars billed, allowed and paid. We also compared volume and cost of a key office-
based code (J2778: Ranibizumab injection) to a key facility-based code (67042: 
vitrectomy for macular hole), and incorporated epidemiology data to understand 
provider incentives and drivers of care. Results: Ophthalmologists represented 
2% of all practitioners billing Part B, but received 7% of reimbursement; the Top 
100 billing ophthalmologists accounted for 0.6% of ophthalmologists billing, but 
received 8.8% of payments; disparities between Top 100 billers and non-Top 100 
include: variety of patients treated, percent of charges reimbursed, and practice 
location; high volume J2778 performers were much more likely to be Top 100 bill-
ers than were high performers of 67042; and based on prevalence among those 
65 and older, a significantly greater percentage of beneficiaries with wet AMD 
received treatment than did beneficiaries with macular hole. cOnclusiOns: 
A large portion of payments were received by relatively few ophthalmologists, 
whose practices demonstrate disparities in variety and volume of procedures 
over non-top billers; incentives—some financial—may be factors that contribute 
to greater treatment of wet AMD than of macular hole; and a focus on conducting 
high-reimbursement services may drive disproportionate system costs. Greater 
transparency may drive changes in practitioner behavior, and reduce unnecessary 
health care system costs.
